Free Account Opening + AMC Free Demat
Loading...

G R Infraprojects IPO vs Tatva Chintan Pharma IPO

Comparision between G R Infraprojects IPO and Tatva Chintan Pharma IPO.

IPO Details

G R Infraprojects IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tatva Chintan Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of G R Infraprojects IPO is up to ₹963.28 Cr whereas the issue size of the Tatva Chintan Pharma IPO is up to ₹500.00 Cr. The final issue price of G R Infraprojects IPO is ₹837.00 per share and of Tatva Chintan Pharma IPO is ₹1,083.00 per share.

  G R Infraprojects IPO Tatva Chintan Pharma IPO
Face Value ₹5 per share ₹10 per share
Issue Price (Lower) ₹828.00 per share ₹1,073.00 per share
Issue Price (Upper) ₹837.00 per share ₹1,083.00 per share
Issue Price (Final) ₹837.00 per share ₹1,083.00 per share
Discount (Retail)
Discount (Employee) ₹42.00 per share
Market Lot Size 17 shares 13 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹225.00 Cr
OFS Issue Size 1,15,08,704 shares
OFS Issue Size (Amount) up to ₹963.28 Cr up to ₹275.00 Cr
Issue Size Total 1,15,08,704 shares
Issue Size Total (Amount) up to ₹963.28 Cr up to ₹500.00 Cr

IPO Timetable

G R Infraprojects IPO opens on Jul 07, 2021, while Tatva Chintan Pharma IPO opens on Jul 16, 2021. The closing date of G R Infraprojects IPO and Tatva Chintan Pharma IPO is Jul 09, 2021, and Jul 20, 2021, respectively.

  G R Infraprojects IPO Tatva Chintan Pharma IPO
Anchor Bid Date
Issue Open Jul 07, 2021 Jul 16, 2021
Issue Close Jul 09, 2021 Jul 20, 2021
Basis Of Allotment (Tentative) Jul 14, 2021 Jul 26, 2021
Initiation of Refunds (Tentative) Jul 15, 2021 Jul 27, 2021
Credit of Share (Tentative) Jul 16, 2021 Jul 28, 2021
Listing date (Tentative) Jul 19, 2021 Jul 29, 2021
Anchor Lockin End date 1 Aug 13, 2021 Aug 25, 2021
Anchor Lockin End date 2 Oct 12, 2021 Oct 24, 2021

Financials

G R Infraprojects IPO P/E ratio is , as compared to Tatva Chintan Pharma IPO P/E ratio of .

  G R Infraprojects IPO Tatva Chintan Pharma IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 1,01,160.45 77,834.16 58,287.31
Total Revenue 79,069.43 64,237.05 53,255.30
Profit After Tax 9,532.21 8,008.32 7,166.38
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 3,148.03 2,489.38 1,875.08
Total Revenue 3,062.92 2,646.22 2,068.01
Profit After Tax 522.62 377.89 205.43
Promoter Shareholding (Pre-Issue) 88.04% 100%
Promoter Shareholding (Post-Issue) 86.54% 79.17%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the G R Infraprojects IPO retail investors (RII) are offered 39,49,297 shares while in Tatva Chintan Pharma IPO retail investors are offered 39,49,297 shares. Qualified institutional buyers (QIB) are offered 56,41,851 shares in G R Infraprojects IPO and 9,31,966 shares in Tatva Chintan Pharma IPO.

  G R Infraprojects IPO Tatva Chintan Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 56,41,851 shares 9,31,966 shares
NII 16,92,556 shares 6,98,975 shares
RII 39,49,297 shares 16,30,941 shares
Employee 2,25,000 shares 0 shares
Others
Total 1,15,08,704 shares 32,61,882 shares

Bids Received (Subscription)

G R Infraprojects IPO subscribed 102.58x in total, whereas Tatva Chintan Pharma IPO subscribed 180.36x.

  G R Infraprojects IPO Tatva Chintan Pharma IPO
QIB (times) 168.58x 185.23x
NII (times) 238.04x 512.22x
Big NII (times)
Small NII (times)
RII (times) 12.57x 35.35x
Employee (times) 1.37x
Other (times)
Total (times) 102.58x 180.36x

Comments

Add a public comment...